{"companyId":272701,"requestedLanguage":"ja","resolvedLanguage":"ja","availableLanguages":["en","ja"],"companyName":"Alpha Cognition Inc.","headOfficeLocation":"1452 Hughes Street, Suite 200, Grapevine, TX 76051, United States","presidentName":"Michael McFadden","companySummary":null,"stockCode":"ACOG","currency":"USD","capital":null,"sales":null,"employees":null,"employeesConsolidated":null,"humanCheck":false,"domains":["alphacognition.com"],"businessContents":["神経変性疾患の治療薬を開発する臨床段階のバイオ医薬品企業。","軽度から中等度のアルツハイマー病認知症の治療薬ZUNVEYL（ベンジガランタミン）を販売。"],"relations":[],"dataSources":[{"detailNumber":1,"url":"https://www.alphacognition.com/","scoreAbout":500,"scoreBusiness":300,"scoreGroup":0,"scoreCustomer":0}]}